Inotersen Subcutaneous and Von willebrand factor recombinant Intravenous
Determining the interaction of Inotersen Subcutaneous and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Subcutaneous-Vonvendi
- Inotersen Subcutaneous-Vopac
- Inotersen Subcutaneous-Vopac MDS
- Inotersen Subcutaneous-Vorapaxar
- Inotersen Subcutaneous-Vorapaxar Sulfate
- Inotersen Subcutaneous-Voraxaze
- Von willebrand factor recombinant Intravenous-Inotuzumab ozogamicin
- Von willebrand factor recombinant Intravenous-Inotuzumab ozogamicin Intravenous
- Von willebrand factor recombinant Intravenous-Inova
- Von willebrand factor recombinant Intravenous-Inova 4/1 topical
- Von willebrand factor recombinant Intravenous-Inova 8/2 topical
- Von willebrand factor recombinant Intravenous-Inova ACT